Omicron News and Research

RSS

The importance of the endosomal pathway for SARS-CoV-2 entry

Researchers demonstrated that combined inhibition of cell-surface-based and endosomal pathways completely blocked SARS-CoV-2 entry into mammalian cells.

21 Mar 2022

Multiple inter-variant recombination events identified in Omicron subvariants

Newly emerging and circulating Omicron subvariants have originated partially through recombination with other variants.

20 Mar 2022

Sinovac COVID vaccine shows modest efficacy against SARS-CoV-2 infection in children 3 to 5 years

Researchers investigate the efficacy of CoronaVac, COVID-19 vaccine developed by Sinovac Biotech, in children aged three to five years.

20 Mar 2022

Omicron BA.1.1 and BA.2 subvariants with new mutations in New Zealand and Hong Kong

A new study describes mutations found in the SARS-CoV-2 BA.1 variant in Hong Kong and New Zealand.

20 Mar 2022

Natural circulating antibodies last for at least seven months in children infected with COVID-19

Children previously infected with COVID-19 develop natural circulating antibodies that last for at least seven months, according to a new study led by researchers at UTHealth Houston.

18 Mar 2022

Texas Biomed and UAB partnership uncovers a new, potent antibody cocktail against all coronaviruses

As SARS-CoV-2 has continued to evolve and outsmart existing treatments, scientists have not let up looking for ever-more effective tools to keep people safe and successfully recover from COVID-19, and to prepare for future outbreaks.

18 Mar 2022

Study evaluates COVID-19 vaccination with recombinant accessory protein-deficient SARS-CoV-2

Researchers assessed the impact of recombinant accessory protein-deficient severe acute respiratory syndrome coronavirus 2 immunization against SARS-CoV-2 transmission and disease severity.

18 Mar 2022

Duration of Omicron variant shedding isolated from upper respiratory samples collected from the reported case-patients in Japan

Researchers conducted a retrospective analysis to evaluate the duration of the SARS-CoV-2 Omicron variant virus shedding

18 Mar 2022

Study explores SARS-CoV-2 spike epitope with potent and broad neutralization

Researchers reported an epitope with high potency and breadth and demonstrated that a therapeutic antibody directed at this site neutralizes all SARS-CoV-2 variants.

18 Mar 2022

COVID-19-related hospitalization among infants and young children in the US

Researchers investigated COVID-19-associated hospitalization among children and infants aged zero to four years in the United States during March 2020 and February 2022.

18 Mar 2022

Researchers argue that Omicron's lower severity is a coincidence

Researchers raised concern regarding the emergence of new SARS-CoV-2 variants with unpredictable severity and immune evasion potential due to its ongoing fast-paced antigenic evolution.

18 Mar 2022

New PCR test uses molecular beacons to identify the specific variant causing COVID-19 infection

After the start of the SARS-C0V-2 pandemic, investigators from ResearchPath LLC and their collaborators at Rutgers University quickly dedicated resources to develop accurate and reliable COVID-19 testing.

17 Mar 2022

Breakthrough infection could provide broad protection against current SARS-CoV-2 variants of concern

A delta breakthrough infection generates a potent and broad neutralizing antibody response in double vaccinated individuals, according to new research.

17 Mar 2022

Why does the SARS-CoV-2 Omicron variant escape immunity?

Researchers reveal the underlying mechanism associated with the Omicron variant’s increased transmissibility and ability to evade immunity.

17 Mar 2022

Immuno-metabolomic signatures that correlate with antigen-specific-T cell response during active COVID-19

Researchers investigate innate and adaptive immune responses at both the early and late stages of SARS-CoV-2 infection.

17 Mar 2022

Impact of new COVID vaccinations as novel variants emerge

Researchers explores the changing value of COVID-19 vaccines in a scenario of dynamic immunity and rapidly evolving variants of concern.

17 Mar 2022

Single dose of Pfizer vaccine reduces risk of SARS-CoV-2 infection in kids

Researchers discuss the efficacy of COVID-19 vaccines in young people and children when the SARS-CoV-2 Delta- and Omicron-dominant periods.

17 Mar 2022

Novel screening method detects new N501T SARS-CoV-2 variant

Researchers develop two SARS-CoV-2 Mutation Discrimination assays that have been designed to detect 501 and 484 mutations on the spike protein.

17 Mar 2022

Study finds out-of-pocket spending for health care after COVID-19 hospital stay

Millions of Americans have needed hospitalization for COVID-19 since the pandemic began, including hundreds of thousands in the recent Omicron surge.

17 Mar 2022

It was already hard to find Evusheld, a covid prevention therapy. Now it’s even harder.

As immunocompromised people across the country work to get Evusheld, a potentially lifesaving covid therapy, several hundred providers of the injections were removed from a federal dataset on Wednesday night, making the therapy even harder to locate.

17 Mar 2022

Omicron News and Research

The importance of the endosomal pathway for SARS-CoV-2 entry

Multiple inter-variant recombination events identified in Omicron subvariants

Sinovac COVID vaccine shows modest efficacy against SARS-CoV-2 infection in children 3 to 5 years

Omicron BA.1.1 and BA.2 subvariants with new mutations in New Zealand and Hong Kong

Natural circulating antibodies last for at least seven months in children infected with COVID-19

Texas Biomed and UAB partnership uncovers a new, potent antibody cocktail against all coronaviruses

Study evaluates COVID-19 vaccination with recombinant accessory protein-deficient SARS-CoV-2

Duration of Omicron variant shedding isolated from upper respiratory samples collected from the reported case-patients in Japan

Study explores SARS-CoV-2 spike epitope with potent and broad neutralization

COVID-19-related hospitalization among infants and young children in the US

Researchers argue that Omicron's lower severity is a coincidence

New PCR test uses molecular beacons to identify the specific variant causing COVID-19 infection

Breakthrough infection could provide broad protection against current SARS-CoV-2 variants of concern

Why does the SARS-CoV-2 Omicron variant escape immunity?

Immuno-metabolomic signatures that correlate with antigen-specific-T cell response during active COVID-19

Impact of new COVID vaccinations as novel variants emerge

Single dose of Pfizer vaccine reduces risk of SARS-CoV-2 infection in kids

Novel screening method detects new N501T SARS-CoV-2 variant

Study finds out-of-pocket spending for health care after COVID-19 hospital stay

It was already hard to find Evusheld, a covid prevention therapy. Now it’s even harder.

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News